Subgroups
Protocols (17)
- therapy-stem-cell-transplant-allogeneic
- therapy-stem-cell-transplant-allogeneic-t-cell-depleted-early-prophylactic-dli-high-risk-leukemia-matched-sibling-donor
- therapy-stem-cell-transplant-allogeneic-t-cell-depleted-early-prophylactic-dli-high-risk-leukemia-ric-matched-sibling-donor
- therapy-stem-cell-transplant-allogeneic-t-cell-depleted-early-prophylactic-dli-high-risk-leukemia-ric-unrelated-donor
- therapy-stem-cell-transplant-allogeneic-t-cell-depleted-early-prophylactic-dli-high-risk-leukemia-unrelated-donor
- therapy-stem-cell-transplant-allogeneic-t-cell-depleted-early-prophylactic-donor-lymphocyte-infusion-high-risk-acute-leukemia
- therapy-stem-cell-transplant-allogeneic-unspecified
- therapy-stem-cell-transplant-cord-blood-ex-vivo-fucosylation
- therapy-stem-cell-transplant-cord-blood-reduced-intensity-conditioning
- therapy-stem-cell-transplant-filgrastim-daily
- therapy-stem-cell-transplant-gvhd-prophylaxis-cyclosporine-methotrexate-generic
- therapy-stem-cell-transplant-gvhd-prophylaxis-tacrolimus-methotrexate-reduced-intensity-conditioning-generic
- therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning
- therapy-stem-cell-transplant-induction-zoledronic-acid-monthly-four-year-generic
- therapy-stem-cell-transplant-induction-zoledronic-acid-monthly-two-year-generic
- therapy-stem-cell-transplant-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic
- therapy-stem-cell-transplant-post-transplant-cyclophosphamide-tacrolimus-mycophenolate-gvhd-prophylaxis-reduced-intensity-conditioning-generic
Outcomes & scoring
No linked evidence yet.
Path: therapy › stem